Skip to content
MedsAcross

Medicine

Propranolol 60 mg tablet

Propranolol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Propranolol 60 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Propranolol
Brand
Sold under the generic name
Strength
60 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1000 tablets and 18 more
Manufacturers
Ipca LaboratoriesIndiaLifestar PharmaIndiaAsclemedAmici PharmaBryant Ranch PrepackAmneal Pharmaceuticals NYCouplerGolden State Medical SupplyMylan PharmaceuticalsPar Health
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C07AA05 Propranolol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 November 1985
Identifiers
RxCUI 856448, 856457, 856519 +2DailyMed set ID d08dbabc-8ca4-426e-a9fd-e7914a27883c, 8efc9fc6-6db0-43c9-892b-7423a9ba679f, b94dcec7-7633-4a33-9cea-48161adeaf93 +8NDC 76420-386, 69292-536, 0378-0187 +8Application ANDA070322, ANDA070213, ANDA071976 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle83980-008-01Ipca LaboratoriesIndia19 September 2024
500 tablet in 1 bottle83980-008-05Ipca LaboratoriesIndia19 September 2024
1000 tablet in 1 bottle83980-008-10Ipca LaboratoriesIndia19 September 2024
30 tablet in 1 bottle83980-008-13Ipca LaboratoriesIndia19 September 2024
100 tablet in 1 bottle70756-297-11Lifestar PharmaIndia27 January 2026
500 tablet in 1 bottle70756-297-51Lifestar PharmaIndia27 January 2026
100 tablet in 1 bottle69292-536-01Amici Pharmaceuticals31 October 2019
1000 tablet in 1 bottle69292-536-10Amici Pharmaceuticals31 October 2019
100 tablet in 1 bottle69238-2080-1Amneal Pharmaceuticals NY3 June 2021
100 tablet in 1 bottle, plastic0378-0187-01Mylan Pharmaceuticals19 November 1985
100 tablet in 1 bottle0603-5485-21Par Health21 June 2010
100 tablet in 1 bottle63629-2280-1Bryant Ranch Prepack10 October 2024
100 tablet in 1 bottle72162-1178-1Bryant Ranch Prepack4 October 2024
1000 tablet in 1 bottle76420-386-00Asclemed31 May 2025
100 tablet in 1 bottle76420-386-01Asclemed31 May 2025
20 tablet in 1 bottle76420-386-20Asclemed31 May 2025
30 tablet in 1 bottle76420-386-30Asclemed31 May 2025
60 tablet in 1 bottle76420-386-60Asclemed31 May 2025
90 tablet in 1 bottle76420-386-90Asclemed31 May 2025
30 tablet in 1 blister pack67046-1582-3Coupler8 September 2025
100 tablet in 1 bottle, plastic51407-239-01Golden State Medical Supply15 May 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 13 November 1967Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Propranolol

Clinical summary

Propranolol is a beta-adrenergic blocker indicated in the management of hypertension, among other approved uses. It is available as tablets, extended-release capsules and oral solution for intravenous use. MedsAcross supplies Propranolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Propranolol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Propranolol 60 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.